6-K ·Filed Jun 5, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No trading action warranted. This is a routine ESOP exercise disclosure with negligible dilution. Monitor upcoming quarterly results for any operational updates.
Final — all horizons settled through T+60d
RDY ▼ -8.38% at T+60d
NEUTRAL call ✗ call lost -8.38% · α vs SPY -12.38% · entry $13.24 → $12.13
T+1d
-0.08%
call -0.08% · α -0.30%
$13.23
settled 4mo ago
T+5d
+0.45%
call +0.45% · α -0.12%
$13.30
settled 4mo ago
T+20d
+8.46%
call +8.46% · α +6.60%
$14.36
settled 3mo ago
T+60d
-8.38%
call -8.38% · α -12.38%
$12.13
settled 4w ago
Price Chart
Loading chart...
Executive Summary
Dr. Reddy's filed a routine 6-K reporting the allotment of 12,100 equity shares upon exercise of stock options under existing ESOP schemes. This is a standard administrative disclosure with no material financial impact.
Key Facts
- Allotted 12,100 equity shares of Re.1 each on June 5, 2026, under Dr. Reddy's Employees Stock Option Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
- Exercise price was Re.1 per share with no premium.
- Total issued shares after allotment: 83,46,70,070 equity shares.
- The shares rank pari passu with existing shares.
Financial Impact
Minimal — 12,100 shares represent less than 0.00015% of total outstanding shares, with no premium received.
dilution
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000406 |
| Document: 0001575872-26-000406-index.html | 0001575872-26-000406 |
| Document: 0001575872-26-000406.txt | 0001575872-26-000406 |
51 reports for RDY
67% Hit rate best @ T+20▲ +23.28%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
Showing 10 of 51
US Market Status
Market Closed — Opens Mon (65h 26m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access